HomeInsightsResults

Syncom Formulations (india) Ltd Quarterly Result

Syncom Formulations (india) Ltd Quarterly Result

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

273.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Syncom Formulations (India) Ltd

NSE: SYNCOMFORMUL

Net Profit

₹ 11.11

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Syncom Formulations (India) Ltd for the Sep '24 is ₹ 106.46 crore as compare to the Jun '24 revenue of ₹ 88.59 crore. This represent the growth of 20.171581%.
  • The ebitda of Syncom Formulations (India) Ltd for the Sep '24 is ₹ 16.31 crore as compare to the Jun '24 ebitda of ₹ 11.79 crore. This represent the growth of 38.33757%.
  • The net profit of Syncom Formulations (India) Ltd for the Sep '24 is ₹ 11.11 crore as compare to the Jun '24 net profit of ₹ 7.63 crore. This represent the growth of 45.60943%.

Results Analysis

Market Price of Syncom Formulations (India) Ltd

1M

1Y

3Y

5Y

Monitoring Syncom Formulations (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202419.51
21 Nov 202419.72
19 Nov 202420.13
18 Nov 202420.24
14 Nov 202420.79
13 Nov 202420.26
12 Nov 202421.2
11 Nov 202420.08
08 Nov 202420.52
07 Nov 202421.27

Historical Revenue of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

05 Nov 202414:12

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 202417:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 202410:30

News

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total e...

Read more

13 Aug 202413:37

News

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

06 Aug 202411:37

News

Syncom Formulations (India) to discuss results

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

09 May 202413:44

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Syncom Formulations India Ltd Quarterly Result

What is the EPS of Syncom Formulations (India) Ltd stock?

The Earnings Per Share (EPS) of Syncom Formulations (India) Ltd is 0.35. An EPS is the amount of net income attributed to each share of a common stock.

How is Syncom Formulations (India) Ltd EPS calculated?

The EPS of Syncom Formulations (India) Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Syncom Formulations (India) Ltd report its EPS?

Syncom Formulations (India) Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Syncom Formulations (India) Ltd EPS?

Factors that influence the EPS of Syncom Formulations (India) Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Syncom Formulations (India) Ltd EPS growth indicate future performance?

Yes, consistent growth in Syncom Formulations (India) Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*